Albertini, V., Jain, A., Vignati, S., Napoli, S., Rinaldi, A., Kwee, I., . . . Catapano, C. V. (2006). Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: Implications for cancer therapy. Oxford University Press.
Styl ChicagoAlbertini, Veronica, et al. Novel GC-rich DNA-binding Compound Produced By a Genetically Engineered Mutant of the Mithramycin Producer Streptomyces Argillaceus Exhibits Improved Transcriptional Repressor Activity: Implications for Cancer Therapy. Oxford University Press, 2006.
Citace podle MLAAlbertini, Veronica, et al. Novel GC-rich DNA-binding Compound Produced By a Genetically Engineered Mutant of the Mithramycin Producer Streptomyces Argillaceus Exhibits Improved Transcriptional Repressor Activity: Implications for Cancer Therapy. Oxford University Press, 2006.